Literature DB >> 18301986

Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma.

Noriyuki Miyamoto1, Kazuhide Hiramatsu, Kazuhiko Tsuchiya, Yukihiko Sato.   

Abstract

PURPOSE: The aim of our study was to evaluate the usefulness of percutaneous radiofrequency ablation (RFA) using CO2 microbubbles-enhanced sonography for patients with local tumor progression of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: The tumors of 14 patients with local progression of HCC were treated with CO2 microbubbles-enhanced RFA ablation via a catheter that had been placed in the hepatic artery. We assessed tumor detectability and technical effectiveness. The mean follow-up period was 14.1 months.
RESULTS: Only 6 of the tumors could be found on conventional sonography, whereas 14 tumors were detected on CO2 microbubbles-enhanced sonography. These 14 lesions were successfully treated with RFA guided by CO2 microbubbles-guided sonography. Technical effectiveness was complete in all patients. No serious complications were observed, and there was no local tumor progression during the follow-up period.
CONCLUSION: RFA guided by CO2 microbubbles-guided sonography is a feasible technique for treating local progression of HCC lesions that cannot be adequately depicted by conventional sonography.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301986     DOI: 10.1007/s11604-007-0198-3

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  32 in total

1.  Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.

Authors:  Yasunori Minami; Masatoshi Kudo; Toshihiko Kawasaki; Hobyung Chung; Chikara Ogawa; Hitoshi Shiozaki
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

2.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

3.  CT-guided treatment of ultrasonically invisible hepatocellular carcinoma.

Authors:  M Sato; Y Watanabe; K Tokui; K Kawachi; S Sugata; J Ikezoe
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

4.  Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver.

Authors:  Rira Watanabe; Manabu Matsumura; Chun-Jen Chen; Yuki Kaneda; Masayoshi Fujimaki
Journal:  Biol Pharm Bull       Date:  2005-06       Impact factor: 2.233

5.  Enhanced sonography using carbon dioxide gas for small hepatocellular carcinoma: a comparison study between pure carbon dioxide gas and carbon dioxide microbubbles.

Authors:  Kazumitsu Koito; Tsutomu Namieno; Naoki Hirokawa; Takeshi Ichimura; Mutsumi Nishida; Naoya Yama; Koichi Sakata; Masato Hareyama; Motoi Nish
Journal:  Radiat Med       Date:  2005-03

6.  Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.

Authors:  Jae Kyun Lee; Young-Hwa Chung; Byung-Cheol Song; Jung Woo Shin; Won-Beom Choi; Soo Hyun Yang; Hyun-Ki Yoon; Kyu-Bo Sung; Yung Sang Lee; Dong Jin Suh
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

7.  Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Tomoya Kawase; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  J Vasc Interv Radiol       Date:  2006-04       Impact factor: 3.464

8.  Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm.

Authors:  Masahiko Koda; Masaru Ueki; Yoshiko Maeda; Ken-ichi Mimura; Kinya Okamoto; Yoshiko Matsunaga; Manri Kawakami; Keiko Hosho; Yoshikazu Murawaki
Journal:  AJR Am J Roentgenol       Date:  2004-09       Impact factor: 3.959

9.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

10.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

Authors:  Riccardo A Lencioni; Hans-Peter Allgaier; Dania Cioni; Manfred Olschewski; Peter Deibert; Laura Crocetti; Holger Frings; Joerg Laubenberger; Ina Zuber; Hubert E Blum; Carlo Bartolozzi
Journal:  Radiology       Date:  2003-05-20       Impact factor: 11.105

View more
  6 in total

Review 1.  Targeted microbubbles: a novel application for the treatment of kidney stones.

Authors:  Krishna Ramaswamy; Vanessa Marx; Daniel Laser; Thomas Kenny; Thomas Chi; Michael Bailey; Mathew D Sorensen; Robert H Grubbs; Marshall L Stoller
Journal:  BJU Int       Date:  2015-03-17       Impact factor: 5.588

2.  Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2009-12-31

Review 3.  Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

4.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato; Satoshi Terae; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

5.  Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

Authors:  Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

Review 6.  Use of carbon dioxide as an intravascular contrast agent: A review of current literature.

Authors:  Fahad Ali; Muhammad Asif Mangi; Hiba Rehman; Edo Kaluski
Journal:  World J Cardiol       Date:  2017-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.